What percentage of total deaths in India are due to myocardial infarction (MI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Percentage of Deaths Due to MI in India

I cannot provide a specific percentage of total deaths in India attributable to myocardial infarction based on the evidence provided, as none of the studies directly report India-specific mortality data for MI as a proportion of all deaths.

What the Evidence Shows

The provided evidence focuses predominantly on Western populations (United States and Europe) and does not contain India-specific cardiovascular mortality statistics. The studies examine:

  • U.S. mortality trends: Heart disease mortality decreased by 66% from 1970 to 2022, with acute MI mortality declining by 89% during this period 1
  • Post-MI mortality rates: After a first MI, approximately 23% of patients die before reaching the hospital, 13% die during hospitalization, and cardiovascular mortality is approximately 10% in the first year and 5% per year thereafter 2
  • Global heart failure data: The 2023 cardiovascular research review includes limited Asian registry data but does not provide India-specific MI mortality proportions 3

Critical Gap in Evidence

None of the guideline documents 3 or research studies 2, 4, 1, 5, 6 contain data specific to India's total mortality burden or the proportion attributable to myocardial infarction.

The evidence provided focuses on:

  • Post-stroke cardiac risk assessment 3
  • U.S. cardiovascular mortality trends 4, 1
  • Post-MI prognosis in Western populations 2
  • Clinical performance measures for MI management 3
  • Diagnostic algorithms for TIA 7

What Would Be Needed

To answer this question accurately, you would need:

  • India-specific vital statistics data from the Registrar General of India
  • National burden of disease studies reporting cause-specific mortality proportions
  • Population-based epidemiological studies from Indian cohorts quantifying MI as a percentage of total deaths

The evidence base provided does not permit calculation of the requested statistic for India's population.

References

Research

Heart Disease Mortality in the United States, 1970 to 2022.

Journal of the American Heart Association, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Trends in Cardiovascular Disease Mortality Rates and Excess Deaths, 2010-2022.

American journal of preventive medicine, 2024

Research

Myocardial infarction in the young and in women.

Cardiovascular clinics, 1989

Guideline

Diagnostic Workup for Transient Ischemic Attack in Patients < 40 Years

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the next best investigation for an asymptomatic, physically active patient with no chronic health issues, who has never smoked, and has a 10-year predicted risk of myocardial infarction (MI) of 6.5% as calculated by the Pooled Cohort Equations (PCE), indicating an intermediate risk of myocardial infarction (MI)?
Can myocardial infarction (MI) occur without atherosclerosis or complete coronary vessel occlusion?
What is the initial management for patients with myocardial infarction without obstructed coronary arteries?
What is the differential diagnosis for a patient presenting with suspected myocardial infarction (MI)?
What is the next best investigation for an asymptomatic, physically active patient with no chronic health issues, who has never smoked, takes no medications, and has a 10-year predicted risk of myocardial infarction (MI) of 6.5% as calculated by the Pooled Cohort Equations (PCE), indicating an intermediate risk of myocardial infarction?
What is the recommended intravenous nicorandil dosing, titration, and monitoring for an adult patient without severe hypotension who requires rapid vasodilation (e.g., refractory angina, acute coronary syndrome, or severe coronary vasospasm)?
What could be causing orthopnea two months after a chest injury and how should it be evaluated and managed?
How should I immediately manage a patient with septic shock, including airway and breathing support, early broad‑spectrum antibiotics, fluid resuscitation, vasopressor therapy, source control, and adjunctive measures?
In a newborn with severe hyperbilirubinemia due to Rh or ABO incompatibility, when is intravenous immunoglobulin (IVIG) indicated, what is the recommended dose and timing, and how should it be monitored?
What does the presence of metamyelocytes on a peripheral blood smear indicate and how should it be evaluated and managed?
In a normotensive adult with chest pain, how should an intravenous nitroglycerin infusion be initiated, titrated, monitored, and what are the contraindications?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.